The largest database of trusted experimental protocols

7 protocols using enhanced chemiluminescence western blot detection system

1

Western Blot Analysis of Immune Signaling Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed as described previously 23. The following primary antibodies were used: monoclonal rat anti‐human GBP‐1 (clone 1B1, hybridoma supernatant, 1:500) 23, polyclonal rabbit anti‐human GBP‐1 1:5000 23, polyclonal rabbit anti‐human caspase‐1 p20 1:200 (sc‐622; Santa Cruz Biotechnology, Dallas, TX, USA), monoclonal rabbit anti‐human caspase‐3 1:1000 (8G10, Cell Signaling, Danvers, MA, USA), monoclonal mouse anti‐human caspase‐5 1:1000 (4F7, MBL, Woburn, MA, USA), monoclonal mouse anti‐human IL‐1β 1:1000 (MAB201; R&D Systems, Minneapolis, MN, USA), monoclonal mouse anti‐Flag 1:2500 (M2; Sigma‐Aldrich), polyclonal rabbit anti‐Flag 1:1000 (F7425; Sigma‐Aldrich) and monoclonal mouse anti‐human GAPDH 1:40,000 (6C5; Millipore, Schwalbach, Germany). All horseradish peroxidase‐conjugated secondary antibodies were diluted 1:5000 and purchased from GE Healthcare. Protein detection was performed using the enhanced chemiluminescence Western blot detection system (ECL; GE Healthcare, Little Chalfont, UK) and Rx‐films (Fuji, Tokyo, Japan) or a chemoluminescence detector (Amersham Imager 600, GE Healthcare). Quantification of Western blot band intensity was performed using the ImageJ software 40.
+ Open protocol
+ Expand
2

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue samples were lysed in ice‐cold RIPA buffer (50 mM Tris‐HCl, pH 8, 12 mM deoxycholic acid, 150 mM NaCl and 1% NP40, supplemented with Complete Protease Inhibitor Cocktail and anti‐phosphatases, Roche) using a Teflon‐on‐glass homogenizer and then centrifuged at 7000 g for 10 min at 4°C. The protein concentration was determined using a BCA protein assay kit (Thermo Fisher Scientific, Inc.). Samples (30 μg) were boiled for 5 min in Laemmli's buffer and run on Bis‐Tris gels with a BoltTM mini gel tank (Invitrogen) using MOPS SDS running buffer BoltTM (Invitrogen). After electrophoresis, proteins were transferred to nitrocellulose membranes using an iBlot®2 gel transfer device (Invitrogen) for blotting with appropriate antibodies. Proteins were visualized with an enhanced chemiluminescence western blot detection system (GE Healthcare Bio‐Sciences AB), after exposure to CL‐XPosure Film (Thermo Scientific).
+ Open protocol
+ Expand
3

Western Blotting from Tissue Lysates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue samples were lysed in ice-cold RIPA buffer (50 mM Tris-HCl, pH 8, 12 mM deoxycholic acid, 150 mM NaCl and 1% NP40, supplemented with Complete Protease Inhibitor Cocktail and anti-phosphatases, Roche) using a Teflon-on-glass homogenizer and then centrifuged at 7000 g for 10 min at 4°C. The protein concentration was determined using a BCA protein assay kit (Thermo Fisher Scientific, Inc.). Samples (30 μg) were boiled for 5min in Laemmli’s buffer and run on Bis-Tris gels with a Bolt™ mini gel tank (Invitrogen) using MOPS SDS running buffer Bolt™ (Invitrogen). After electrophoresis, proteins were transferred to nitrocellulose membranes using an iBlot®2 gel transfer device (Invitrogen) for blotting with appropriate antibodies. Proteins were visualized with an enhanced chemiluminescence western blot detection system (GE Healthcare Bio-Sciences AB), after exposure to CL-XPosure Film (Thermo Scientific).
+ Open protocol
+ Expand
4

Western Blot Analysis of Liver Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The liver tissues were homogenized in 500 μl of a RIPA buffer (Sigma-Aldrich, St. Loius, MO, USA) for protein extraction. The protein (40 μg) was then separated on a 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and electrotransferred onto polyvinylidene difluoride membranes. The membranes were incubated in a blocking solution (5% bovine serum albumin) at room temperature for 2 h and then incubated with a primary antibody (OB-R, SREBP-1, FAS, JAK2, AMPK, ACC, STAT3 or β-actin) overnight at 4 °C. After washing, the membranes were incubated with a goat anti-rabbit immunoglobulin G peroxidase-conjugated secondary antibody. The membranes were developed using an enhanced chemiluminescence western blot detection system (GE Healthcare Biosciences, Pittsburgh, PA, USA) as described previously.12 , 23 (link), 24 (link)
+ Open protocol
+ Expand
5

Western Blot Analysis of DLK1 Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Western blot analyses, cells were lysed in RIPA buffer (Sigma-Aldrich, Laramie, WY, USA) with complete mini protease inhibitors (Roche, Indianapolis, IN, USA). The proteins were quantified using the Bradford assay (Bio-Rad, Hercules, CA, USA), separated using NU-PAGE gel (NOVEX) electrophoresis and transferred to nitrocellulose membranes (Amersham Hybond; GE Healthcare, Chicago, IL, USA). Following blocking with 5% skimmed milk in TBS (0.1% Tween 20), membranes were left overnight at 4℃ in an anti-DLK1 primary antibody solution (1:100; Millipore, Burlington, MA, USA). The anti-β-actin antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was used as a housekeeping molecule. These blots were then labeled with horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology) for 1 hour at 4℃. The membranes were washed with TBST (Tris Buffered Saline with Tween 20, 0.1%; Sigma-Aldrich) and the target protein was detected by an enhanced chemiluminescence Western blot detection system (GE, Berlin, Germany). The relative expression level of each protein was calculated by comparing β-actin expression level.
+ Open protocol
+ Expand
6

Western Blot Analysis of NMDA-2A

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total protein of cells was extracted by radioimmunoprecipitation assay (RIPA) lysis buffer (Cat: R0010) with phenylmethanesulfonyl fluoride (Cat: ST506), and quantified by BCA protein assay kit (Cat: 10136–1). The β‐tubulin antibody (Lot: 334077) was used as the loading control for Western blot analysis to confirm equivalent protein loading in different groups. Same amounts of proteins derived from cell lysates were resolved by SDS‐PAGE and transferred onto nitrocellulose membranes. Nonspecific binding was blocked by 5% skim milk in phosphate buffer saline at room temperature for 2 h. After washing three times with tris‐buffered saline Tween‐20 (TBST), the membranes were incubated with rabbit anti‐NMDA‐2A antibody (Lot: 00083510) diluted 1:800 in TBST and rabbit anti‐tubulin antibody (Lot: 334077) diluted 1:1000 in TBST at 4°C overnight. In addition, the membranes were washed three times with TBST and incubated with corresponding secondary antibodies conjugated with horseradish peroxidase at room temperature for another 2 h. Enhanced chemiluminescence Western blot detection system (GE Healthcare) was utilized to visualize antibody‐binding conjugates. Image‐J software (1.8.0) was used to quantify the bands.
+ Open protocol
+ Expand
7

Western Blot Analysis of Protein Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot analysis was performed on proteins (10–30 μg) isolated from whole cell lysates, as described previously. The following primary antibodies were used: rabbit polyclonal anti-APJ (1:1000; ab84296, Abcam), rabbit monoclonal anti-PDGFR-β (1:10,000; ab32570, Abcam), and rabbit polyclonal anti-β-actin (1:5,000; NB600-532H, Novus Biologicals). Corresponding horseradish peroxidase-conjugated secondary antibodies (DAKO) were subsequently applied. Signals were visualized with an enhanced chemiluminescence western blot detection system (GE Healthcare UK Ltd).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!